NASDAQ:INO   Inovio Pharmaceuticals, Inc.
INO is revealing head and neck cancer data on November 8-12
It is currently sitting on its 50 day EMA and a past resistance/support level.
Entry: 6.24
Stop Loss: 5.80
Profit Target: 7.00, maybe more
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。